The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liquid Biopsy Products Market Research Report 2024
Synopsis
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The global Liquid Biopsy Products market was valued at US$ 1714 million in 2023 and is anticipated to reach US$ 8549.7 million by 2030, witnessing a CAGR of 25.5% during the forecast period 2024-2030.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Products.
Report Scope
The Liquid Biopsy Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Biopsy Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Segment by Type
CTCs
ctDNA
Exosomes
Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
This report mainly covers the Liquid Biopsy Products product type by technology (circulating Tumor Cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes)), by sample type (blood, urine and other bio fluids (Tissue fluids and Saliva based)), while we can also offer any product survey report related to the liquid biopsy products industry chain.
The global Liquid Biopsy Products market was valued at US$ 1714 million in 2023 and is anticipated to reach US$ 8549.7 million by 2030, witnessing a CAGR of 25.5% during the forecast period 2024-2030.
The major players in global Liquid Biopsy Products market include RainDanceTechnologies, Biocartis, Qiagen, etc. The top 3 players occupy about 15% shares of the global market. North America is the main market. CTCs is the main type, with a share about 65%. Blood Sample is the main application, which holds a share about 90%.
This report aims to provide a comprehensive presentation of the global market for Liquid Biopsy Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Biopsy Products.
Report Scope
The Liquid Biopsy Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Biopsy Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Biopsy Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
RainDanceTechnologies
Biocartis
Qiagen
Guardant Health
MDxHealth
Pathway Genomics
NeoGenomics Laboraories
Sysmex Inostics
Cynvenio
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc
Segment by Type
CTCs
ctDNA
Exosomes
Segment by Application
Blood Sample
Urine Sample
Other Bio Fluids
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Biopsy Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Biopsy Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 CTCs
1.2.3 ctDNA
1.2.4 Exosomes
1.3 Market by Application
1.3.1 Global Liquid Biopsy Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Blood Sample
1.3.3 Urine Sample
1.3.4 Other Bio Fluids
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Biopsy Products Market Perspective (2019-2030)
2.2 Liquid Biopsy Products Growth Trends by Region
2.2.1 Global Liquid Biopsy Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid Biopsy Products Historic Market Size by Region (2019-2024)
2.2.3 Liquid Biopsy Products Forecasted Market Size by Region (2025-2030)
2.3 Liquid Biopsy Products Market Dynamics
2.3.1 Liquid Biopsy Products Industry Trends
2.3.2 Liquid Biopsy Products Market Drivers
2.3.3 Liquid Biopsy Products Market Challenges
2.3.4 Liquid Biopsy Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Biopsy Products Players by Revenue
3.1.1 Global Top Liquid Biopsy Products Players by Revenue (2019-2024)
3.1.2 Global Liquid Biopsy Products Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Biopsy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Biopsy Products Revenue
3.4 Global Liquid Biopsy Products Market Concentration Ratio
3.4.1 Global Liquid Biopsy Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Biopsy Products Revenue in 2023
3.5 Liquid Biopsy Products Key Players Head office and Area Served
3.6 Key Players Liquid Biopsy Products Product Solution and Service
3.7 Date of Enter into Liquid Biopsy Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Biopsy Products Breakdown Data by Type
4.1 Global Liquid Biopsy Products Historic Market Size by Type (2019-2024)
4.2 Global Liquid Biopsy Products Forecasted Market Size by Type (2025-2030)
5 Liquid Biopsy Products Breakdown Data by Application
5.1 Global Liquid Biopsy Products Historic Market Size by Application (2019-2024)
5.2 Global Liquid Biopsy Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liquid Biopsy Products Market Size (2019-2030)
6.2 North America Liquid Biopsy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liquid Biopsy Products Market Size by Country (2019-2024)
6.4 North America Liquid Biopsy Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Biopsy Products Market Size (2019-2030)
7.2 Europe Liquid Biopsy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liquid Biopsy Products Market Size by Country (2019-2024)
7.4 Europe Liquid Biopsy Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy Products Market Size (2019-2030)
8.2 Asia-Pacific Liquid Biopsy Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liquid Biopsy Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Liquid Biopsy Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Biopsy Products Market Size (2019-2030)
9.2 Latin America Liquid Biopsy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liquid Biopsy Products Market Size by Country (2019-2024)
9.4 Latin America Liquid Biopsy Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy Products Market Size (2019-2030)
10.2 Middle East & Africa Liquid Biopsy Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liquid Biopsy Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Liquid Biopsy Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 RainDanceTechnologies
11.1.1 RainDanceTechnologies Company Detail
11.1.2 RainDanceTechnologies Business Overview
11.1.3 RainDanceTechnologies Liquid Biopsy Products Introduction
11.1.4 RainDanceTechnologies Revenue in Liquid Biopsy Products Business (2019-2024)
11.1.5 RainDanceTechnologies Recent Development
11.2 Biocartis
11.2.1 Biocartis Company Detail
11.2.2 Biocartis Business Overview
11.2.3 Biocartis Liquid Biopsy Products Introduction
11.2.4 Biocartis Revenue in Liquid Biopsy Products Business (2019-2024)
11.2.5 Biocartis Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Detail
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Liquid Biopsy Products Introduction
11.3.4 Qiagen Revenue in Liquid Biopsy Products Business (2019-2024)
11.3.5 Qiagen Recent Development
11.4 Guardant Health
11.4.1 Guardant Health Company Detail
11.4.2 Guardant Health Business Overview
11.4.3 Guardant Health Liquid Biopsy Products Introduction
11.4.4 Guardant Health Revenue in Liquid Biopsy Products Business (2019-2024)
11.4.5 Guardant Health Recent Development
11.5 MDxHealth
11.5.1 MDxHealth Company Detail
11.5.2 MDxHealth Business Overview
11.5.3 MDxHealth Liquid Biopsy Products Introduction
11.5.4 MDxHealth Revenue in Liquid Biopsy Products Business (2019-2024)
11.5.5 MDxHealth Recent Development
11.6 Pathway Genomics
11.6.1 Pathway Genomics Company Detail
11.6.2 Pathway Genomics Business Overview
11.6.3 Pathway Genomics Liquid Biopsy Products Introduction
11.6.4 Pathway Genomics Revenue in Liquid Biopsy Products Business (2019-2024)
11.6.5 Pathway Genomics Recent Development
11.7 NeoGenomics Laboraories
11.7.1 NeoGenomics Laboraories Company Detail
11.7.2 NeoGenomics Laboraories Business Overview
11.7.3 NeoGenomics Laboraories Liquid Biopsy Products Introduction
11.7.4 NeoGenomics Laboraories Revenue in Liquid Biopsy Products Business (2019-2024)
11.7.5 NeoGenomics Laboraories Recent Development
11.8 Sysmex Inostics
11.8.1 Sysmex Inostics Company Detail
11.8.2 Sysmex Inostics Business Overview
11.8.3 Sysmex Inostics Liquid Biopsy Products Introduction
11.8.4 Sysmex Inostics Revenue in Liquid Biopsy Products Business (2019-2024)
11.8.5 Sysmex Inostics Recent Development
11.9 Cynvenio
11.9.1 Cynvenio Company Detail
11.9.2 Cynvenio Business Overview
11.9.3 Cynvenio Liquid Biopsy Products Introduction
11.9.4 Cynvenio Revenue in Liquid Biopsy Products Business (2019-2024)
11.9.5 Cynvenio Recent Development
11.10 Menarini Silicon Biosystems
11.10.1 Menarini Silicon Biosystems Company Detail
11.10.2 Menarini Silicon Biosystems Business Overview
11.10.3 Menarini Silicon Biosystems Liquid Biopsy Products Introduction
11.10.4 Menarini Silicon Biosystems Revenue in Liquid Biopsy Products Business (2019-2024)
11.10.5 Menarini Silicon Biosystems Recent Development
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Detail
11.11.2 Adaptive Biotechnologies Business Overview
11.11.3 Adaptive Biotechnologies Liquid Biopsy Products Introduction
11.11.4 Adaptive Biotechnologies Revenue in Liquid Biopsy Products Business (2019-2024)
11.11.5 Adaptive Biotechnologies Recent Development
11.12 Biocept
11.12.1 Biocept Company Detail
11.12.2 Biocept Business Overview
11.12.3 Biocept Liquid Biopsy Products Introduction
11.12.4 Biocept Revenue in Liquid Biopsy Products Business (2019-2024)
11.12.5 Biocept Recent Development
11.13 Angle plc
11.13.1 Angle plc Company Detail
11.13.2 Angle plc Business Overview
11.13.3 Angle plc Liquid Biopsy Products Introduction
11.13.4 Angle plc Revenue in Liquid Biopsy Products Business (2019-2024)
11.13.5 Angle plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
